📰 Lon Ins News
Lon Ins News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Lon Ins. Real-time updates on events, politics, business and more.
July 20, 2023
Shares of Instem plc (LON:INS – Get Free Report) crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 638.72 ($8.35) and traded as low as GBX 612 ($8.00). Instem shares last traded at GBX 615 ($8.04), with a volume of 14,728 shares changing hands. […]
July 20, 2023
Instem plc (LON:INS – Get Free Report) shares crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 638.72 ($8.35) and traded as low as GBX 612 ($8.00). Instem shares last traded at GBX 615 ($8.04), with a volume of 14,728 […]
May 13, 2023
Instem plc (LON:INS – Get Rating) passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 655.07 ($8.27) and traded as low as GBX 640 ($8.08). Instem shares last traded at GBX 640 ($8.08), with a volume of 17,945 shares changing hands. Instem Trading Up […]
April 1, 2023
Shares of Instem plc (LON:INS – Get Rating) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 653.17 ($8.03) and traded as low as GBX 620 ($7.62). Instem shares last traded at GBX 627.50 ($7.71), with a volume of 5,308 shares changing hands. Instem […]
March 24, 2023
Shares of Instem plc (LON:INS – Get Rating) crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of GBX 654.34 ($8.04) and traded as low as GBX 635 ($7.80). Instem shares last traded at GBX 635 ($7.80), with a volume of 10,260 shares traded. Instem Stock […]
May 19, 2021
Instem lays foundations for next level in drug development services “Businesses in life sciences have so many suppliers and so many different solutions that it is a huge opportunity.” Two acquisitions this year already underline the growing ambition of pharmaceutical services group Instem PLC (LON:INS). In a sector where its customers are usually valued in the billions, a desire by Instem to bulk up is understandable. The business currently is valued at £150mln (at 680p) which by AIM sta...
April 12, 2021
Instem swings to profit as revenue boosted by new, existing business wins